今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 532次   下载 1267 本文二维码信息
码上扫一扫!
分享到: 微信 更多
姜黄素-多巴胺纳米药物用于脑胶质瘤细胞的化疗-光热联合治疗
江正平, 张燕, 王强松
中国医学科学院生物医学工程研究所, 天津 300192
摘要:
[目的]探索一种药物递送系统改善姜黄素水溶性差、体内代谢快等问题,实现姜黄素-光热联合治疗脑胶质瘤细胞的目的。[方法]利用盐酸多巴胺在弱碱性条件下能够自聚合为聚多巴胺的特性,制备包封姜黄素的聚多巴胺纳米粒(PDA@CUR NPs),对纳米粒的粒径、粒径稳定性、表面Zeta电位、载药量、包封率、药物释放和光热转换性能进行考察;细胞水平上,利用激光扫描共聚焦显微镜探讨PDA@CUR NPs跨越血脑屏障的体外模拟和脑胶质瘤细胞对PDA@CUR NPs的摄取行为;通过细胞增殖及毒性实验,评估了PDA@CUR NPs对脑胶质瘤细胞的“化疗+光热疗法”联合治疗效果。[结果]PDA@CUR NPs粒径大小约275 nm,分布均匀,稳定性良好,载药量(11.41±0.27)%,包封率(81.73±2.22)%,在近红外光的外源性刺激下,5 min内温度能够达到约45℃;实现对负载姜黄素的光热及pH响应控制释放;细胞实验结果表明:PDA@CUR NPs能够跨越带孔小室(孔径0.4 μm),脑胶质瘤细胞能够摄取纳米粒,且姜黄素与光热的联合对脑胶质瘤细胞有显著的抑制杀伤作用。[结论]PDA@CUR NPs能够明显改善姜黄素水溶性、稳定性差和体内代谢快等问题,为化疗协同光热或其他疗法的联合治疗脑胶质瘤提供了新的思路。
关键词:  姜黄素  脑胶质瘤  纳米药物控释  化疗-光热联合治疗
DOI:10.11656/j.issn.1672-1519.2023.02.18
分类号:R739.41
基金项目:
Curcumin-dopamine nanomedicines for combined chemo-photothermal therapy of glioma cell
JIANG Zhengping, ZHANG Yan, WANG Qiangsong
Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, Tianjin 300192, China
Abstract:
[Objective] To explore a drug delivery system to improve the poor water solubility of curcumin and rapid metabolism in vivo,and to achieve the purpose of curcumin-photothermal combination therapy for glioma cells.[Methods] Using the characteristics that dopamine hydrochloride can self-polymerize into polydopamine under weakly alkaline conditions,polydopamine nanoparticles (PDA@CUR NPs) entrapped curcumin were prepared to investigate the particle size,particle size stability,surface zeta potential,drug loading,entrapment efficiency,drug release and photothermal conversion properties of nanoparticles;at the cellular level,laser scanning confocal microscopy was used to investigate the in vitro simulation of PDA@CUR NPs crossing the blood-brain barrier and the uptake behavior of PDA@CUR NPs by glioma cells. Through cell proliferation and toxicity experiments,the combined therapeutic effect of PDA@CUR NPs on glioma cells was assessed.[Results] PDA@CUR NPs had a particle size of about 275 nm,uniform distribution and good stability,with a drug loading of (11.41±0.27)% and an entrapment efficiency of (81.73±2.22)% and the temperature could reach about 45℃ within 5 min under exogenous stimulation with near-infrared light. The photothermal and pH response of curcumin-loaded NPs was controlled and released. The results of cell experiments showed that PDA@CUR NPs could bypass the pored chamber(pore size 0.4 μm),glioma cells could uptake nanoparticles and the combination of curcumin and photothermal had a significant inhibitory killing effect on glioma cells.[Conclusion] PDA@CUR NPs can significantly improve the water solubility,poor stability and rapid metabolism of curcumin in vivo,providing a new idea for the combined treatment of glioma with chemotherapy combined with photothermal or other therapies.
Key words:  curcumin  glioma  nanomedicine controlled release  combined chemo-photothermal therapy
关注公众号二维码